US 12,108,666 B2
Compound and organic electroluminescence device
Ryota Takahashi, Sodegaura (JP); Hidetsugu Ikeda, Sodegaura (JP); Yuki Nakano, Sodegaura (JP); and Keita Seda, Sodegaura (JP)
Assigned to IDEMITSU KOSAN CO., LTD., Tokyo (JP)
Appl. No. 17/278,419
Filed by IDEMITSU KOSAN CO.,LTD., Tokyo (JP)
PCT Filed Sep. 26, 2019, PCT No. PCT/JP2019/037865
§ 371(c)(1), (2) Date Mar. 22, 2021,
PCT Pub. No. WO2020/067290, PCT Pub. Date Apr. 2, 2020.
Application 17/278,419 is a continuation in part of application No. 16/355,222, filed on Mar. 15, 2019, granted, now 10,593,889, issued on Mar. 17, 2020.
Claims priority of application No. 2018-180465 (JP), filed on Sep. 26, 2018.
Prior Publication US 2021/0395233 A1, Dec. 23, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. H10K 85/60 (2023.01); C07D 403/14 (2006.01); C07D 491/22 (2006.01); C07D 519/00 (2006.01); C09K 11/06 (2006.01); H10K 50/11 (2023.01); H10K 50/15 (2023.01); H10K 50/16 (2023.01); H10K 50/17 (2023.01)
CPC H10K 85/657 (2023.02) [C07D 403/14 (2013.01); C07D 491/22 (2013.01); C07D 519/00 (2013.01); C09K 11/06 (2013.01); H10K 85/626 (2023.02); H10K 85/631 (2023.02); H10K 85/654 (2023.02); H10K 85/6572 (2023.02); H10K 85/6574 (2023.02); C09K 2211/1018 (2013.01); H10K 50/11 (2023.02); H10K 50/15 (2023.02); H10K 50/16 (2023.02); H10K 50/17 (2023.02); H10K 50/171 (2023.02)] 23 Claims
OG exemplary drawing
 
1. A compound having a structure represented by the following formulas (a) and (b):

OG Complex Work Unit Chemistry
wherein, in the formulas (a) and (b),
ring A, ring B, ring C and ring D are independently selected from
a substituted or unsubstituted phenyl group, a substituted or unsubstituted biphenyl group, a substituted or unsubstituted terphenylyl group, a substituted or unsubstituted naphthyl group, a substituted or unsubstituted anthryl group, a substituted or unsubstituted benzanthryl group, a substituted or unsubstituted phenanthryl group, a substituted or unsubstituted benzophenanthryl group, a substituted or unsubstituted phenalenyl group, a substituted or unsubstituted pyrenyl group, a substituted or unsubstituted chrysenyl group, a substituted or unsubstituted benzochrysenyl group, a substituted or unsubstituted triphenylenyl group, a substituted or unsubstituted benzotriphenylenyl group, a substituted or unsubstituted tetracenyl group, a substituted or unsubstituted pentacenyl group, a substituted or unsubstituted fluorenyl group, a substituted or unsubstituted 9,9′-spirobifluorenyl group, a substituted or unsubstituted benzofluorenyl group, a substituted or unsubstituted dibenzofluorenyl group, a substituted or unsubstituted fluoranethenyl group, a substituted or unsubstituted benzofluoranthenyl group, or a substituted or unsubstituted perylenyl group, or
a substituted or unsubstituted heterocyclic ring having 5 to 50 ring atoms;
two or more of ring A, ring B, ring C and ring D are heterocyclic rings; and
each of sites *a, *b, *c and *d in the formula (a) and the formula (b) represents a position of an atom, and the atoms located in the sites *a, *b, *c and *d form one substituted or unsubstituted and saturated or unsaturated six-membered ring including four atoms thereof, wherein the substituted or unsubstituted heterocylic ring having 5 to 50 ring atoms represented by ring A to ring DA independently has a structure selected from dibenzofuran, benzimidazole, indolocarbazole, pyridine, pyrazine, pyridazine, pyrimidine, triazine, quinoline, isoquinoline, quinazoline, cinnoline, phthalazine, quinoxaline, pyrrole, indole, pyrrolo[3.2.1-jk]carbazole, furan, benzofuran, thiophene, benzothiophene, pyrazole, imidazole, benzimidazole, triazole, oxazole, benzoxazole, thiazole, benzothiazole, isothiazole, benzisothiazole, thiadiazole, isoxazol, benzisoxazole, pyrrolidine, piperidine, piperazine, imidazolidine, carbazole, indro[3.2.1-jk]carbazole and dibenzothiophene, or a heterocyclic structure containing the structure thereof as a partial structure.